UBS Group’s Asterias Biotherapeutics Inc. Series A AST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-219
| Closed | – | – | 7520 |
|
|
2018
Q4 | $0 | Sell |
219
-2,898
| -93% | – | ﹤0.01% | 7574 |
|
|
2018
Q3 | $4K | Buy |
3,117
+2,621
| +528% | +$3.36K | ﹤0.01% | 6705 |
|
|
2018
Q2 | $0 | Buy |
496
+322
| +185% | – | ﹤0.01% | 7497 |
|
|
2018
Q1 | $0 | Sell |
174
-5,009
| -97% | – | ﹤0.01% | 7410 |
|
|
2017
Q4 | $12K | Buy |
5,183
+3,878
| +297% | +$8.98K | ﹤0.01% | 5971 |
|
|
2017
Q3 | $4K | Sell |
1,305
-58
| -4% | -$178 | ﹤0.01% | 6446 |
|
|
2017
Q2 | $5K | Buy |
1,363
+459
| +51% | +$1.68K | ﹤0.01% | 6234 |
|
|
2017
Q1 | $3K | Sell |
904
-2,976
| -77% | -$9.88K | ﹤0.01% | 6327 |
|
|
2016
Q4 | $18K | Buy |
3,880
+3,206
| +476% | +$14.9K | ﹤0.01% | 5655 |
|
|
2016
Q3 | $3K | Sell |
674
-41
| -6% | -$182 | ﹤0.01% | 6426 |
|
|
2016
Q2 | $2K | Sell |
715
-2,091
| -75% | -$5.85K | ﹤0.01% | 6582 |
|
|
2016
Q1 | $13K | Buy |
2,806
+226
| +9% | +$1.05K | ﹤0.01% | 5680 |
|
|
2015
Q4 | $10K | Buy |
2,580
+2,137
| +482% | +$8.28K | ﹤0.01% | 6037 |
|
|
2015
Q3 | $2K | Sell |
443
-234
| -35% | -$1.06K | ﹤0.01% | 6659 |
|
|
2015
Q2 | $3K | Sell |
677
-4,230
| -86% | -$18.7K | ﹤0.01% | 6508 |
|
|
2015
Q1 | $33K | Buy |
4,907
+1,558
| +47% | +$10.5K | ﹤0.01% | 4994 |
|
|
2014
Q4 | $11K | Buy |
+3,349
| New | +$11K | ﹤0.01% | 5986 |
|